Payment processing companies have good prospects. The trend will continue to be good. They are expensive, however.

It is a money-centered, large bank in the US. It was an amazing bank but in recent years they got caught cross selling things to people that they should not have. They had a change in management. He hopes earnings growth will start again under this new management. (Analysts’ price target is $49.80)

Heath care stocks have not been in favour. JNJ-N has been in the penalty box with the opioid lawsuits. They only had 1% of the sales in this, however. (Analysts’ price target is $148.53)

6.5% yield. The market put them in the penalty box due to an acquisition. (Analysts’ price target is $30.85)

North American banks have gone sideways, including JPM. JPM has been rangebound since early 2018. It tends to bounce off $110 and hits a ceiling of $120. That's one approach. Another approach is to see if it breaks-out above $120 and buy it then.

Enter now at $137 and add to a position? He owns a lot for the long-term. MSFT has been going up for a long while. Occasionally, it consolidates or pullbacks? Not bad to buy it now. Nothing wrong with this chart.

This morning, he was looking at it. He likes it, but hasn't bought it yet. It's now consolidating after a long downtrend. It recently broke-out on a China deal announcement, but has fallen to a neckline--and entry point--around $20. He doubts there is much downside coming, so you can buy it now or very soon.